Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $698,509 - $781,452
8,286 Added 100.38%
16,541 $1.53 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $753,400 - $992,486
-10,386 Reduced 55.72%
8,255 $788,000
Q4 2023

Feb 07, 2024

BUY
$61.71 - $77.76 $486,645 - $613,215
7,886 Added 73.32%
18,641 $1.42 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $722,036 - $973,206
10,422 Added 3129.73%
10,755 $745,000
Q2 2023

Jul 24, 2023

BUY
$81.41 - $94.33 $27,109 - $31,411
333 New
333 $31,000
Q2 2022

Aug 10, 2022

SELL
$86.5 - $128.27 $43,077 - $63,878
-498 Reduced 62.33%
301 $29,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $28,140 - $35,421
-276 Reduced 25.67%
799 $94,000
Q4 2021

Feb 15, 2022

BUY
$106.37 - $130.68 $531 - $653
5 Added 0.47%
1,075 $139,000
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $6,997 - $8,347
-68 Reduced 5.98%
1,070 $122,000
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $95,409 - $119,216
1,138 New
1,138 $118,000
Q1 2021

May 13, 2021

SELL
$78.68 - $90.67 $33,281 - $38,353
-423 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $8,316 - $10,582
116 Added 37.79%
423 $39,000
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $20,627 - $26,844
307 New
307 $25,000
Q2 2020

Aug 13, 2020

SELL
$57.54 - $76.95 $4,027 - $5,386
-70 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$52.41 - $81.0 $102,304 - $158,112
-1,952 Reduced 96.54%
70 $14,000
Q4 2019

Feb 11, 2020

BUY
$71.7 - $82.09 $133,433 - $152,769
1,861 Added 1155.9%
2,022 $472,000
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $6,278 - $7,693
102 Added 172.88%
161 $35,000
Q2 2019

Aug 06, 2019

SELL
$55.74 - $64.41 $2,787 - $3,220
-50 Reduced 45.87%
59 $11,000
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $2,825 - $3,778
59 Added 118.0%
109 $21,000
Q4 2018

Feb 11, 2019

BUY
$46.41 - $56.94 $2,320 - $2,847
50 New
50 $8,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.